Dianthus Therapeutics (DNTH) Net Income Growth (3y) (2020 - 2025)
Dianthus Therapeutics (DNTH) Net Income Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 79.26% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -107.04% |
| Jun 30, 2025 | -19.21% |
| Mar 31, 2025 | -13.74% |
| Dec 31, 2024 | 4.61% |
| Sep 30, 2024 | -46.27% |
| Jun 30, 2024 | -38.03% |
| Mar 31, 2024 | 11.24% |
| Dec 31, 2023 | 45.43% |
| Sep 30, 2023 | 2.21% |
| Jun 30, 2023 | 24.19% |
| Mar 31, 2023 | 36.16% |
| Dec 31, 2022 | 49.26% |
| Sep 30, 2022 | 13.52% |
| Jun 30, 2022 | -5.65% |
| Mar 31, 2022 | -11.52% |
| Dec 31, 2021 | 16.61% |
| Sep 30, 2021 | 21.73% |
| Jun 30, 2021 | -8.36% |
| Mar 31, 2021 | -32.16% |
| Dec 31, 2020 | -65.38% |